How to Buy Beone Medicines Stock
Beone Medicines Ltd
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies.
Beone Medicines stock last closed at $365.82, down 0.69% from the previous day, and has increased 89.26% in one year. It has overperformed other stocks in the Biotechnology industry by 1.38 percentage points. Beone Medicines stock is currently +113.94% from its 52-week low of $170.99, and -4.05% from its 52-week high of $381.25.
There are currently 1.44B shares of ONC outstanding. The market cap of ONC is $40.52B. In the past 24 hours, 230,000 ONC shares were traded.
How to Buy Beone Medicines Stock
Not sure how to invest in Beone Medicines stock? Here's how.
- Choose where to buy Beone Medicines stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Beone Medicines stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Select your method of payment and add your details.
- Evaluate Beone Medicines stock: The Beone Medicines ticker symbol is ONC. Is Beone Medicines stock a good investment? Should you buy shares of ONC? How do ONC's underlying business fundamentals look? Do top analysts think Beone Medicines is a good buy? Why has ONC's stock price moved recently? (Hint: Our stock market research tools can help you figure out if ONC is a good stock to buy).
- Place your ONC purchase: Decide if you will purchase ONC shares at the current market price or use a limit order to buy ONC shares at a given price.
- Monitor your ONC position: Create a watchlist to monitor your investment in Beone Medicines stock.
Step 1: Choose where to buy Beone Medicines stock
You will need an online brokerage account in order to access the NASDAQ market and buy ONC shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal details so you can invest in ONC stock today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to open a new brokerage account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've filled out your info on mobile trading apps, you need to deposit funds:
Check out the tutorial below to see the process of depositing money into your new brokerage account.
Step 4: Evaluate Beone Medicines stock
Once you have selected the best place to buy Beone Medicines stock, it's very important to research their stock before you buy, so you actually wrap your head around the risk as well as the opportunity.
Beone Medicines shares quick numbers
ONC Due Diligence Score
WallStreetZen was built to help everyday investors do more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ONC's stock page.
Is ONC stock properly valued?
Analysts use many financial metrics, analyses, models, and charts to gauge ONC's fair value.
Using relative valuations measures:
- ONC may be overvalued based on its P/E ratio of 7,316.4x, relative to Biotechnology industry P/E ratio of 281.87x
- ONC could be overvalued based on its P/B ratio of 9.81x, relative to Biotechnology industry P/B ratio of 5.09x
- ONC may be overvalued based on its PEG ratio of 19.56x
You can access additional valuation research on ONC's stock here.
Is ONC a healthy company?
Positive Health Checks:
- ONC earnings of $162.08M is not enough to cover its interest payments.
- ONC's operating cash flow of $785.39M allows it to safely service it's debt of $1.90B.
- ONC profit margin has gone up from -25.9% to 1.4% in the past year.
- There are more short-term assets than short-term liabilities on the ONC balance sheet.
- There are more short-term assets than long-term liabilities on the ONC balance sheet.
Negative Health Checks:
- Total ONC debt is higher than 5 years ago, relative to shareholder equity.
- ONC has a relatively high debt to equity ratio of 0.85.
Is ONC stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Wall Street analysts who give recommendations on ONC, the consensus analyst rating on ONC is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest ONC Analyst Recommendations
Peter Lawson, a bottom 5% analyst from Barclays initiates coverage on ONC with a strong buy rating and announces their ONC price target of $385.00, on Sep 18, 2025.
Michael Schmidt, a top 2% analyst from Guggenheim maintains ONC with a strong buy rating and raises their ONC price target from $350.00 to $365.00, on Aug 7, 2025.
You can dive deeper into what analysts are projecting on the Beone Medicines stock forecast page.
ONC Technicals
Is ONC Growing Revenue?
Last year, ONC revenue was $4.97B. During the last five year, ONC's revenue has gone up by 79.66% per year. This was faster than the Biotechnology industry average of 42.56%.
You can analyze ONC's earnings and revenue performance here.
What are ONC executives and large shareholders up to?
Over the past 12 months, executives and large shareholders at ONC have sold more shares than they have bought.
Xiaobin Wu, President and COO of ONC, was the latest ONC insider to sell. They sold $1,612,582.24 worth of ONC shares on Nov 13, 2025.
Learn more about who owns ONC shares here.
Does ONC provide a stable income stream?
No, Beone Medicines doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your ONC purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular price limit, place a limit order.
Click the Open Trade button and eToro will execute your order.
If you need additional help investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your ONC position
Now that you own some ONC shares, you'll want to keep up with your new shares.
Put ONC on a watchlist to track the latest developments regarding your ONC stock.
ONC Feed
How to Buy Stock in Beone Medicines
To summarize, here are the 6 steps you need to take to buy Beone Medicines stock right now:
- Choose where to buy Beone Medicines stock
- Create your brokerage account
- Put funds into your investment account
- Evaluate Beone Medicines stock
- Place your ONC purchase
- Monitor your ONC position
If you need a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get updates on your investment in Beone Medicines, add ONC to your watchlist by clicking the button below.
More Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.